51. Glucagon-like peptide-2 improves intestinal immune function and diminishes bacterial translocation in a mouse model of parenteral nutrition
- Author
-
Xuejin Gao, Feng Tian, Huanwei Chen, Jingcheng Bi, Qiucheng Lei, Ning Li, and Xinying Wang
- Subjects
Male ,Parenteral Nutrition ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Adaptive Immunity ,Biology ,Random Allocation ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Endocrinology ,Immune system ,Internal medicine ,Glucagon-Like Peptide 2 ,medicine ,Animals ,Intestinal Mucosa ,Saline ,Barrier function ,Mice, Inbred ICR ,Interleukin-13 ,Nutrition and Dietetics ,digestive, oral, and skin physiology ,Receptors, Polymeric Immunoglobulin ,Interleukin ,Glucagon-like peptide-2 ,Immunity, Innate ,Disease Models, Animal ,Phospholipases A2 ,Parenteral nutrition ,chemistry ,Bacterial Translocation ,030220 oncology & carcinogenesis ,Immunoglobulin A, Secretory ,Muramidase ,030211 gastroenterology & hepatology ,Interleukin-4 ,Lysozyme ,Polymeric immunoglobulin receptor - Abstract
Parenteral nutrition (PN) is associated with increased infectious risks due to impaired intestinal immunity. Although glucagon-like peptide-2 (GLP-2) enhances the gut barrier function, it is uncertain whether it improves mucosal immunologic barrier function. We hypothesized that injecting the PN mouse model with GLP-2 improved innate and acquired immunity, and prevented bacterial translocation. Forty-eight hours after venous cannulation, male Institute of Cancer Research mice were randomly divided into 3 groups based on their diet: chow with saline (n = 10), PN (n = 9), or PN + GLP-2 (30 μg bid per mouse, n = 10) provided for 5 days. Compared with chow, PN reduced interleukin (IL)-4 and IL-13 levels (P < .05, respectively), whereas, compared with PN alone, GLP-2 injection increased IL-4 and IL-13 levels (P < .05, respectively). Compared with chow, PN considerably suppressed, whereas GLP-2 improved, secretory phospholipase A2 and cryptdin-4 expression. PN, compared with chow, considerably decreased lysozyme and polymeric immunoglobulin receptor levels, whereas, compared with PN, GLP-2 significantly increased these protein levels (P < .01, respectively). In tissue and luminal samples, compared with chow, PN reduced secretory immunoglobulin A levels (P < .05), whereas, compared with PN alone, GLP-2 increased secretory immunoglobulin A levels (P < .05). Functionally, more bacterial translocation was observed in the PN group compared with the chow group (P < .001), and GLP-2 injection decreased bacterial translocation to chow levels (P < .05). In summary, GLP-2 treatment may improve intestinal innate and acquired immunity, and prevent bacterial translocation in mice on total parenteral nutrition.
- Published
- 2018